Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Jesper Hjortnaes - , Brigham and Women's Hospital, University Medical Center (UMC) Utrecht (Author)
  • Claudia Goettsch - , Brigham and Women's Hospital (Author)
  • Joshua D Hutcheson - , Brigham and Women's Hospital (Author)
  • Gulden Camci-Unal - , Brigham and Women's Hospital, Massachusetts Institute of Technology (MIT) (Author)
  • Lilian Lax - , Brigham and Women's Hospital (Author)
  • Katrin Scherer - , Brigham and Women's Hospital (Author)
  • Simon Body - , Brigham and Women's Hospital (Author)
  • Frederick J Schoen - , Brigham and Women's Hospital (Author)
  • Jolanda Kluin - , University Medical Center (UMC) Utrecht (Author)
  • Ali Khademhosseini - , Harvard University, Brigham and Women's Hospital, Massachusetts Institute of Technology (MIT) (Author)
  • Elena Aikawa - , Brigham and Women's Hospital (Author)

Abstract

PURPOSE: Calcific aortic valve disease (CAVD) is the most prevalent valve disease in the Western world. Recent difficulty in translating experimental results on statins to beneficial clinical effects warrants the need for understanding the role of valvular interstitial cells (VICs) in CAVD. In two-dimensional culture conditions, VICs undergo spontaneous activation similar to pathological differentiation, which intrinsically limits the use of in vitro models to study CAVD. Here, we hypothesized that a three-dimensional (3D) culture system based on naturally derived extracellular matrix polymers, mimicking the microenvironment of native valve tissue, could serve as a physiologically relevant platform to study the osteogenic differentiation of VICs.

PRINCIPAL RESULTS: Aortic VICs loaded into 3D hydrogel constructs maintained a quiescent phenotype, similar to healthy human valves. In contrast, osteogenic environment induced an initial myofibroblast differentiation (hallmarked by increased alpha smooth muscle actin [α-SMA] expression), followed by an osteoblastic differentiation, characterized by elevated Runx2 expression, and subsequent calcific nodule formation recapitulating CAVD conditions. Silencing of α-SMA under osteogenic conditions diminished VIC osteoblast-like differentiation and calcification, indicating that a VIC myofibroblast-like phenotype may precede osteogenic differentiation in CAVD.

MAJOR CONCLUSIONS: Using a 3D hydrogel model, we simulated events that occur during early CAVD in vivo and provided a platform to investigate mechanisms of CAVD. Differentiation of valvular interstitial cells to myofibroblasts was a key mechanistic step in the process of early mineralization. This novel approach can provide important insight into valve pathobiology and serve as a promising tool for drug screening.

Details

Original languageEnglish
Pages (from-to)13-20
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume94
Publication statusPublished - May 2016
Peer-reviewedYes
Externally publishedYes

External IDs

PubMedCentral PMC4906202
Scopus 84962242928
ORCID /0000-0002-7973-1329/work/184443320

Keywords

Sustainable Development Goals

Keywords

  • Actins/genetics, Animals, Aortic Valve/metabolism, Aortic Valve Stenosis/etiology, Apoptosis, Biomarkers, Calcinosis/etiology, Cell Culture Techniques, Cell Cycle, Cell Differentiation, Cell Survival, Fluorescent Antibody Technique, Gene Silencing, Humans, Hydrogels, In Vitro Techniques, Myofibroblasts/cytology, Phenotype, Swine